INTERCEPT Blood System

The INTERCEPT Blood System is a technology used to enhance blood safety by reducing the risk of transmitting infections through blood transfusions. It works by treating donated blood with a special solution and exposing it to ultraviolet (UV) light, which inactivates bacteria, viruses, and other pathogens without damaging the blood components. This process helps ensure that transfusions are safer for patients, especially in cases where the infection status of the donor cannot be fully known. Developed by Cerus Corporation, the system aims to improve overall transfusion safety and reduce the incidence of transfusion-related infections.